TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly through suppressing BTG2 and activating BCL2

Table 1 Correlation between MNX1-AS1 expression and clinicopathological features of GC

Clinical parameter	MNX1-AS1 expression		Chi-squared test P-value
Clinical parameter	High expression cases (n = 87)	Low expression cases (n = 87)	Chi-squared test P-value
Age (years)			0.263
≤ 50	14	9
> 50	73	78
Gender			0.598
Male	67	64
Female	20	23
Size			0.004 *
≥ 5 cm	52	33
< 5 cm	35	54
Location			0.288
Distal	49	42
Middle and Proximal	38	45
Invasion depth			< 0.001 *
T1/T2	9	33
T3/T4	78	54
Histologic differentiation			0.035 *
Well and Moderately	28	42
Poorly	58	45
TNM Stages			< 0.001 *
I/II	32	63
III/IV	55	24
Lymphatic metastasis			0.002 *
Yes	69	50
No	18	37
Distant metastasis			0.009 *
Yes	11	2
No	76	85

ISSN: 1476-4598